Skip to content

Study · Animal study (in vivo) · rat · 2018

2 results

[Pharmacokinetics of noopept and its active metabolite cycloprolyl glycine in rats].

Boyko SS, Zherdev VP, Shevchenko RV

Biomeditsinskaia khimiia1 Sept 2018Cited by 1 (Europe PMC)

PMID30378564 (opens in a new tab)DOI10.18097/pbmc20186405455 (opens in a new tab)PepBankPUB-30378564
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Pharmacokinetics

    In rats given Noopept, its metabolite cyclo-prolyl-L-glycine was found in plasma and brain.

    In plain wordsIn rats given Noopept, its metabolite was found in blood plasma and brain.

    Peptide
    Noopept (omberacetam)
    Outcome
    Not applicableActive metabolite distribution
    Study

    ratn: not reported in source

    Outcome group
    Pharmacokinetics · Pharmacology
    Studied dose
    Dose not stated

    Source sentences

    Summary
    studies of its pharmacokinetics in ratsrevealed that the noopept metabolite found in the rat plasma and brain, cyclo-prolyl-L-glycine (CPG), differed significantly in its pharmacokinetic parameters from noopept
  2. 02AnimalAnimal study (in vivo)Pharmacokinetics

    In rats, Noopept and its metabolite cyclo-prolyl-L-glycine differed significantly in pharmacokinetic parameters.

    In plain wordsIn rats, Noopept and its metabolite had significantly different pharmacokinetic properties.

    Peptide
    Noopept (omberacetam)
    Outcome
    Direction not reportedMetabolite pharmacokinetic difference
    Study

    ratn: not reported in source

    Comparator
    Cyclo-prolyl-L-glycine metabolite
    Outcome group
    Pharmacokinetics · Pharmacology
    Studied dose
    Dose not stated

    Source sentences

    Summary
    studies of its pharmacokinetics in ratsrevealed that the noopept metabolite found in the rat plasma and brain, cyclo-prolyl-L-glycine (CPG), differed significantly in its pharmacokinetic parameters from noopept

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    21 Oct 2026, 15:58 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 12:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.